-+ 0.00%
-+ 0.00%
-+ 0.00%

MicroPort Artemis Dream intracranial stent enters China NMPA innovative device review program

PUBT·09/08/2026 16:16:41
Listen to the news
MicroPort Artemis Dream intracranial stent enters China NMPA innovative device review program
  • MicroPort’s Artemis Dream intracranial sirolimus-eluting stent entered China’s NMPA Innovative Medical Device Special Review “Green Channel” on Sep. 8, 2026.
  • The move adds an expedited regulatory review pathway for registration, not marketing authorization.
  • Artemis Dream targets intracranial artery stenosis, a key contributor to ischemic stroke.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MicroPort Scientific Corporation published the original content used to generate this news brief on September 08, 2026, and is solely responsible for the information contained therein.